However, TRPA1 antagonists have not been specifically tested for migraine so far although a series of high affinity and selective TRPA1 antagonists are currently undergoing phase I and phase II clinical trials for various diseases characterized by pain component [166]. Here, TRPA1 is linked to migraine disorder.